Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distribution Agreement to Improve Automated Hemostasis Diagnostics

By LabMedica International staff writers
Posted on 23 Aug 2015
A new, exclusive-distributer agreement will lead to creating a unique high-performance hemostatis work cell by connecting a laboratory automation system (LAS) from Thermo Fisher Scientific (Waltham, MA, USA) with a hemostasis testing LAS from Instrumentation Laboratory (IL; Bedford, MA, USA).

The agreement between IL and Thermo Fisher appoints IL as the exclusive worldwide distributor for the Thermo Scientific TCAutomation LAS in the field of hemostasis. More...
IL will offer state-of-the-art "Hemostasis Lab Automation Work Cell" solutions, comprised of their ACL TOP 700/750 LASs integrated with the TCAutomation LAS. Hemostasis labs considering automation can now rely on leading hemostasis expertise of IL coupled with leading automation expertise of Thermo Fisher, to provide them with tailored LAS solutions for standardization and work-load management.

"Hospitals all over the world are being asked to do more with less. The IL-Thermo Fisher Hemostasis Work Cell is an ideal solution for laboratories who seek to increase the efficiency of their operations, while enhancing the quality of their hemostasis laboratory test results," said Ramon Benet, CEO, IL, "The excellent performance of our ACL TOP 700/750 LAS testing systems, which are ideally suited for lab automation integration, will be further enhanced through the Thermo Fisher TCAutomation LAS."

In 2012, the companies signed an agreement allowing IL to distribute TCAutomation. IL then successfully implemented their ACL TOP 700 systems on TCAutomation in several key customer sites. Now, their partnership is further strengthened: "This new agreement marks an important expansion in our partnership with IL," said Marc Tremblay, president, Clinical Diagnostics, Thermo Fisher, "We are excited to combine our fully featured TCAutomation solution with ACL TOP 700/750 LAS systems to create a complete and optimized automation offering in the field of hemostasis."

Designed to provide more efficient, cost-effective workflow through modularity, flexibility, and connectivity, TCAutomation offers solutions for automating the most labor-intensive pre- and post-analytical tasks, with an open concept that supports direct interfaces to a wide range of analyzers. Interfacing ACL TOP 700/750 with TCAutomation, and automating the key pre- and post-analytical steps (such as decapping, centrifugation, aliquoting, sorting, storing and recapping), introduces a compact automation Work Cell solution. TCAutomation can be easily expanded with additional modules to help meet future needs and requirements to increase efficiency, productivity, and safety.

The ACL TOP line delivers efficiency, flexibility, and superior performance. For routine to specialty testing in mid- to high-volume labs, each system in this standardized platform provides the same quality results, comprehensive HemosIL reagent line, powerful intuitive software, and features. IL’s Hemostasis Portfolio includes the “ACL TOP Family” of automated, high-productivity analyzers (models: 700/700 CTS/700 LAS; 500 CTS; and 300 CTS) and now the new “ACL TOP Family 50 Series” offering advanced automation and quality management features (models: 750/750 CTS/750 LAS; 550 CTS; and 350 CTS).

The ACL TOP Family 50 Series represents a breakthrough in hemostasis testing. Recently introduced in Western Europe and Japan, this line offers assay-specific pre-analytical sample checks, advanced lab accreditation support, and advanced quality management. Commercialization will continue in a phased global process through 2016, based on regulatory registrations and other considerations.

IL also offers other hemostasis analyzers (ACL AcuStar, ACL ELITE, and others). In addition to its hemostasis line, IL offers critical care systems and information management systems.

Related Links:

Instrumentation Laboratory
Thermo Fisher Scientific



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.